"Pericarditis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inflammation of the PERICARDIUM from various origins, such as infection, neoplasm, autoimmune process, injuries, or drug-induced. Pericarditis usually leads to PERICARDIAL EFFUSION, or CONSTRICTIVE PERICARDITIS.
Below are MeSH descriptors whose meaning is more general than "Pericarditis".
Below are MeSH descriptors whose meaning is more specific than "Pericarditis".
This graph shows the total number of publications written about "Pericarditis" by people in this website by year, and whether "Pericarditis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Pericarditis" by people in Profiles.
Reported Pericardial Toxicities Associated with Acute Myelogenous Leukemia Treatments: A Pharmacovigilance Analysis of the FDA Adverse Reporting Database. Curr Probl Cardiol. 2022 11; 47(11):101345.
Current pharmacotherapy management of children and adults with pericarditis: Prospectus for improved outcomes. Pharmacotherapy. 2021 12; 41(12):1041-1055.
Rilonacept: A Newly Approved Treatment for Recurrent Pericarditis. Ann Pharmacother. 2022 05; 56(5):572-581.
Clinical and economic outcomes associated with hospitalizations for acute idiopathic pericarditis in the United States. Heart Lung. 2021 Nov-Dec; 50(6):825-831.
Managing acute and recurrent idiopathic pericarditis. JAAPA. 2020 Jan; 33(1):16-22.
Management of Acute Idiopathic (Viral) Pericarditis in the Emergency Department: A Review for the Nursing Professional. Adv Emerg Nurs J. 2020 Jan/Mar; 42(1):17-29.
Pharmacotherapeutic Management Strategies for Thyroid Disease-Induced Pericarditis. Ann Pharmacother. 2020 05; 54(5):486-495.
Pharmacists' Role in the Management of Acute and Recurrent Pericarditis: Inpatient and Outpatient Perspectives. J Pharm Pract. 2020 Dec; 33(6):838-845.
Treatment of Adults with Idiopathic Recurrent Pericarditis: Novel Use of Immunotherapy. Pharmacotherapy. 2017 03; 37(3):305-318.
Pharmacotherapeutic considerations for using colchicine to treat idiopathic pericarditis in the USA. Am J Cardiovasc Drugs. 2015 Oct; 15(5):295-306.